Why would you say neop isn't a good investment right now.
they have approved medical devices, the cardiosonix just got approved late last year and is ready to launch.
The riggs will start a phase 3 for a billion dollar market that can be approved for a standard of care product in early 2006, and lymphoseek may start a phase 3 trial late this year with a trial that may be funded by the NIH.
where can you get all that for a 30 million dollar market cap
Dew diligence says price is what you pay value is what you get.
In this case he doesn't like this stock, I don't really care but for this stock he says the market has it right.
they only have it wrong in the stocks he likes.
Market Data 
Markets 
AI
